openPR Logo
Press release

Rising Prevalence Of Chronic Diseases To Drive Market Growth: A Leading Driver Behind Structural Biology And Molecular Modeling Techniques Market Expansion in 2025

06-30-2025 12:23 PM CET | Health & Medicine

Press release from: The Business Research Company

Structural Biology And Molecular Modeling Techniques

Structural Biology And Molecular Modeling Techniques

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Structural Biology And Molecular Modeling Techniques Industry Market Size Be by 2025?
Acceleration in the growth of the structural biology and molecular modeling techniques market has been witnessed in the past few years. The market size is projected to escalate from $8.78 billion in 2024 to $10.35 billion in 2025, with a compound annual growth rate (CAGR) of 17.9%. The significant expansion during the historical period is due to factors such as the advent of cryo-electron microscopy, strides made in pharmaceutical research and drug discovery, a better grasp of enzyme techniques, advancements in structural genomics initiatives, validation of drug targets, structural revelations pertaining to viral proteins, and studies related to drug resistance.

What's the Long-Term Growth Forecast for the Structural Biology And Molecular Modeling Techniques Market Size Through 2029?
The market for structural biology and molecular modeling techniques is predicted to experience significant increase in the upcoming years, with an expected value of $20.36 billion in 2029 and a compound annual growth rate (CAGR) of 18.4%. This projected growth during the forecast period can be attributed to the expansion of fragment-based drug design, advancements in hybrid methods, rapid rise of structural proteomics, applications of precision medicine in oncology, uses of structural biology in neuroscience research, its role in RNA biology, and the progress in structural bioinformatics. Noteworthy trends during this forecast period consist of the introduction of artificial intelligence (ai), advanced hybrid methods for structural determination, single-particle analysis in cryo-EM, the structures of membrane proteins, the development of open-source software, NMR spectroscopy, the use of structural biology in personalized medicine, and the technological progression in x-ray crystallography.

View the full report here:
https://www.thebusinessresearchcompany.com/report/structural-biology-and-molecular-modeling-techniques-global-market-report

What Are the Key Growth Drivers Fueling the Structural Biology And Molecular Modeling Techniques Market Expansion?
The escalating occurrence of long-lasting diseases is anticipated to drive the expansion of the structural biology and molecular modeling techniques industry. These chronic ailments typically persist for more than three months and can progressively deteriorate over time. Cancer, heart disease, stroke, diabetes, and arthritis are among the most common chronic diseases. Structural biology is deployed to explore the root causes of diseases and structure-guided methods have proven to be significant in many facets of preliminary drug discovery, both theoretically and practically. The structural framework contributes to comprehending the impacts of genetic disease mutations in humans and the implications of resistance to cancer and infectious disease treatments. For example, the Australian Institute of Health and Welfare, a government organization in Australia, reported in June 2024 that mortality caused by chronic conditions surged from 459 per 100,000 in 2021 to 490 per 100,000 in 2022, signifying a substantial upswing. For this reason, the increase in chronic disease prevalence is stimulating the growth of the structural biology and molecular modeling techniques market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8532&type=smp

What Are the Key Trends Driving Structural Biology And Molecular Modeling Techniques Market Growth?
The structural biology and molecular modeling techniques market is increasingly being influenced by technological advancements. To maintain their market position, prominent companies are innovating and creating new technologies, including next-generation sequencing-based ctDNA testing, 3-D chemical structure silico screening, and sophisticated software. As a case in point, PerkinElmer Inc., a US-based firm that offers products and services for the applied services, life sciences, and diagnostics markets, unveiled its ChemDraw V21 software in March 2022. This tool offers easy and quick native import, animation, and the ability to share 3D chemical structures in Microsoft PowerPoint, making it faster and simpler for chemists to generate in-depth research reports. Using the new ChemDraw V21 software allows scientists to insert a live 3D model of their molecule into Microsoft PowerPoint and then view, rotate, and share the image, with all atom and bond colour highlights perfectly retained.

How Is the Structural Biology And Molecular Modeling Techniques Market Segmented?
The structural biology and molecular modeling techniques market covered in this report is segmented -

1) By Tools: SaaS And Standalone Modeling, Visualization And Analysis, Databases, Other Tools
2) By Application: Drug Development, Drug Discovery, Other Applications
3) By End-Users: Pharmaceutical, Biotechnological, Academic, Clinical Trial

Subsegments:
1) By SaaS And Standalone Modeling: Cloud-Based Modeling Tools, Desktop Modeling Software
2) By Visualization And Analysis: Molecular Visualization Software, Structural Analysis Tools
3) By Databases: Protein Structure Databases, Molecular Interaction Databases
4) By Other Tools: Simulation Software, Docking Software, Other Analytical Tools

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8532&type=smp

Which Companies Are Leading the Charge in Structural Biology And Molecular Modeling Techniques Market Innovation?
Major companies operating in the structural biology and molecular modeling techniques market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Agile Molecule Inc., Bruker Corporation, Dassault Systèmes SE, Illumina Inc., Chemical Computing Group ULC, Biomax Informatics AG, Horiba Ltd., Charles River Laboratories Inc., Adjuvance Technologies Inc., Novartis AG, QIAGEN N.V., Avanti Polar Lipids Inc., Acellera Ltd., Schrödinger Inc., OpenEye Scientific Software Inc., BioSolveIT GmbH, Optibrium Ltd., Simulations Plus Inc., Certara L.P., Genedata AG, Inte:Ligand GmbH, Molecular Networks GmbH, Molecular Discovery Ltd., Cresset Group Ltd., Biotherapeutics Inc., Biovista Inc., Collaborative Drug Discovery Inc., Dotmatics Ltd., Insilico Biotechnology AG, Leadscope Inc.

Which Regions Are Leading the Global Structural Biology And Molecular Modeling Techniques Market in Revenue?
North America was the largest region in the structural biology and molecular modelling techniques market in 2024. The regions covered in the structural biology and molecular modeling techniques market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8532

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Prevalence Of Chronic Diseases To Drive Market Growth: A Leading Driver Behind Structural Biology And Molecular Modeling Techniques Market Expansion in 2025 here

News-ID: 4086764 • Views:

More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Model

Animal Model Market
The Global Animal Model Market, detailed in the TechSci Research report titled, "Animal Model Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028," exhibited a value of USD 1.67 billion in 2022, poised to grow at a Compound Annual Growth Rate (CAGR) of 7.64% from 2024 to 2028. This comprehensive analysis delves into the intricate web of factors driving the market, including the global burden of chronic
Executing a Business Model Transformation with A Business Model Canvas
Business model transformation is the process of changing the way a company operates, with the aim of improving its overall performance. This transformation often involves significant changes to a company's existing business model. To ensure that the transformation process is successful, companies can use a tool called the business model canvas. Get a free business model canvas here: https://digitalleadership.com/unite-articles/extended-business-model-canvas/ Steps in Executing a Business Model Transformation with A Business Model Canvas Business
Fourth Party Logistics Market : Industry Innovator Model, Solution Integrator Mo …
The fourth party logistics market was valued at $57.9 billion in 2021, and is estimated to reach $111.7 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031. Fourth party logistics, popularly known as 4PL, is the model of outsourcing of logistics operations, where the service provider integrates with the company's supply chain department. This logistics partner is responsible for assessing, designing, building, running, and measuring integrated supply
How Drizly Works: Business Model & Revenue Model
‘Slow and steady wins the race.’ Such is the case with the world’s leading alcohol marketplace, Drizly which carved a unique, step-by-step growth strategy for itself and eventually, succeeded in transforming the way alcohol is bought and sold across various continents. Co-founded in 2012 by Cory Rellas and Nick Rellas, the Boston-based start-up which was one of the first few on-demand liquor delivery apps to make its way into the market,
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market Developing Regions to Overpower Developed Ones With Regard to Demand The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their
Cloud Computing in Healthcare Market By Deployment Model (Public- cloud deployme …
Industry Outlook and Trend Analysis The Cloud Computing in Healthcare Market was worth USD 3.05 billion in 2014 and is expected to reach approximately USD 16.25 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 20.43% during the forecast period. Cloud computing, commonly alluded to as 'the cloud', is a technique to access and store the information and projects over the internet. The cloud computing is